MCE
Bortezomib
Bortezomib
Bortezomib (PS-341) is a reversible and selective proteasome inhibitor, and potently inhibits 20S proteasome (Ki=0.6 nM) by targeting a threonine residue. Bortezomib disrupts the cell cycle, induces apoptosis, and inhibits NF-κB. Bortezomib is the first proteasome inhibitor anticancer agent. Anti-cancer activity.
Couldn't load pickup availability
General Specifications
1) Purity: 99.99%2) Molecular Weight: 384.24
3) Formula: C19H25BN4O4
4) CAS No.: 179324-69-7
5) Appearance: Solid
6) Color: White to off-white
7) SMILE: OB(O)[C@H](CC(C)C)NC([C@@H](NC(C1=NC=CN=C1)=O)CC2=CC=CC=C2)=O
8) Shipping: Room temperature in continental US; may vary elsewhere.
9) Storage: 4°C, protect from light ; In solvent: -80°C, 6 months ; -20°C, 1 month (protect from light)
Safety & Documentation
Error in entry: 1) Datasheet, https://cdn.shopify.com/s/files/1/0716/2553/9802/files/Datasheet_HY-10227.pdf?v=1734506157 , 2) MSDS, https://cdn.shopify.com/s/files/1/0716/2553/9802/files/MSDS_HY-10227.pdf?v=1734506829 , 3) Handling Instruction, https://cdn.shopify.com/s/files/1/0716/2553/9802/files/Handling_Instructions_HY-10227.pdf?v=1734506807
{# This line will help debug any improperly formatted entries #}
Disclaimer: Products are chemical reagents for research use
only and are not intended for human use. We do not sell to patients.